FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ondrej Topolcan

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Pilot Projects

Co-author Network

Publications

TOP 3
Martin Pesta; Ondrej Topolcan; Jakub Fichtl; Vlastimil Kulda; Vladislav Treska
Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
Martin Pesta; Jarmil Safranek; Ondrej Topolcan; Radim Cerny; Ondrej Fiala; Gabriela Krakorova; Vlastimil Kulda; M Pesek
Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer.
Karin Bunatova; Vlastimil Kulda; Ladislav Pecen; Martin Pesta; Alan Sutnar; Ondrej Topolcan; Vladislav Treska; Jindra Vrzalova; Vaclav Liska
Plasma TIMP1 level is a prognostic factor in patients with liver metastases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ondrej Topolcan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin Pesta; Ondrej Topolcan; Jakub Fichtl; Vlastimil Kulda; Vladislav Treska
Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
Anticancer research 2013;33(5):2239-43.
2012: Martin Pesta; Jarmil Safranek; Ondrej Topolcan; Radim Cerny; Ondrej Fiala; Gabriela Krakorova; Vlastimil Kulda; M Pesek
Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer.
Anticancer research 2012;32(11):5003-10.
2012: Karin Bunatova; Vlastimil Kulda; Ladislav Pecen; Martin Pesta; Alan Sutnar; Ondrej Topolcan; Vladislav Treska; Jindra Vrzalova; Vaclav Liska
Plasma TIMP1 level is a prognostic factor in patients with liver metastases.
Anticancer research 2012;32(10):4601-6.
2012: Zdenek Novotny; Jiri Presl; Lucie Betincova; Radka Fuchsova; Radek Kucera; Ondrej Topolcan; Jindra Vrzalova; Zdenek Rokyta
HE4 and ROMA index in Czech postmenopausal women.
Anticancer research 2012;32(9):4137-40.
2012: Jiri Polivka; Jiri Polivka; Vladimir Rohan; Ondrej Topolcan; Jiri Ferda
New molecularly targeted therapies for glioblastoma multiforme.
Anticancer research 2012;32(7):2935-46.
2012: Stefan Holdenrieder; J Dreslerova; Jindrich Finek; Vaclav Liska; V M Matejka; Petra Stieber; Ondrej Topolcan; V Treska; Lubos Holubec
Cytokeratin serum biomarkers in patients with colorectal cancer.
Anticancer research 2012;32(5):1971-6.
2012: Lada Eberlová; Karel Houdek; J Kocová; Marie Korabecná; Vera Krízková; Vlastimil Kulda; Jirí Molácek; Lukás Nedorost; Martin Pesta; Zbynek Tonar; Ondrej Topolcan; Vladislav Treska; Ludmila Boudová; Jindra Vrzalová; Jirí Valenta
[Morphology and etiopathogenesis of the abdominal aortic aneurysm].
Casopís lékar̆ů c̆eských 2012;151(2):55-63.
2011: Martin Pesta; Marketa Prazakova; Jarmil Safranek; Jan Bruha; Lubos Holubec; Radek Kucera; Vlastimil Kulda; Vaclav Liska; Ladislav Pecen; M Pesek; Vladislav Treska; Jindra Vrzalova; Ondrej Vycital; Ondrej Topolcan
Prognostic significance of TIMP-1 in non-small cell lung cancer.
Anticancer research 2011;31(11):4031-8.
2011: Petr Pazdiora; Ladislav Pecen; Milos Pesek; Marketa Prazakova; Marketa Strakova; Sarka Svobodova; Jindrich Finek; Radka Fuchsova; Lubos Holubec; Radek Kucera; Andrea Narsanska; Vladislav Treska; Inka Treskova; Jindra Vrzalova; Ondrej Topolcan
Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.
Anticancer research 2011;31(10):3619-21.
2011: Marketa Prazakova; Jarmil Safranek; Marketa Spisakova; Sarka Svobodova; Ondrej Topolcan; Jindra Vrzalova; Josep Maria Auge; Radka Fuchsova; Lubos Holubec; Martin Pesta
The role of MonoTotal in the primary diagnosis, prognosis and follow-up of patients with non-small cell lung cancer (NSCLC).
Anticancer research 2011;31(9):3107-12.
2011: Vladislav Treska; J Vrzalová; J Fichtl; Vaclav Liska; A Narsanská; T Skalický; F Slauf; Alan Sutnar; Ondrej Topolcan; M Vachtová
[Can tumor markers predict outcomes of portal vein branch embolization in patients with primary inoperable liver tumors?].
Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti 2011;90(5):285-9.
2011: Vaclav Liska; Lubos Holubec; Vladislav Treska; Jindra Vrzalova; Tomas Skalicky; Alan Sutnar; Stanislav Kormunda; Jan Bruha; Ondrej Vycital; Jindrich Finek; Martin Pesta; Ladislav Pecen; Ondrej Topolcan
Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer.
Anticancer research 2011;31(4):1447-51.
2011: Sarka Svobodova; Ondrej Topolcan; Lubos Holubec; Miroslav Levy; Ladislav Pecen; Stepan Svacina
Parameters of biological activity in colorectal cancer.
Anticancer research 2011;31(1):373-8.
2011: Vladislav Treska; Ondrej Topolcan; Jindra Vrzalova; Tomas Skalicky; Alan Sutnar; Vaclav Liska; Jakub Fichtl; Andrea Narsanska; Jiri Ferda; Inka Treskova; H Mirka; Boris Kreuzberg
Predictive value of serum biomarkers in patients after portal vein embolization (PVE): a pilot study.
Anticancer research 2011;31(1):339-44.
2010: Martin Pesta; J Klecka; V Kulda; Ondrej Topolcan; M Hora; V Eret; M Ludvikova; M Babjuk; K Novak; J Stolz; Lubos Holubec
Importance of miR-20a expression in prostate cancer tissue.
Anticancer research 2010;30(9):3579-83.
2010: Vlastimil Kulda; Martin Pesta; Ondrej Topolcan; Vaclav Liska; Vladislav Treska; Alan Sutnar; K Rupert; Marie Ludvikova; Vaclav Babuska; Lubos Holubec; Radim Cerny
Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases.
Cancer genetics and cytogenetics 2010;200(2):154-60.
2009: Zdenka Ulcova-Gallova; Jitka Gruberova; Jindra Vrzalova; Katarina Bibkova; Jana Peknicova; Zdenka Micanova; Ondrej Topolcan
Sperm antibodies, intra-acrosomal sperm proteins, and cytokines in semen in men from infertile couples.
American journal of reproductive immunology (New York, N.Y. : 1989) 2009;61(3):236-45.
2009: Jindra Vrzalova; Marketa Prazakova; Zdenek Novotny; Ondrej Topolcan; Miroslava Casova; Lubos Holubec
Test of ovarian cancer multiplex xMAP technology panel.
Anticancer research 2009;29(2):573-6.
2008: Ondrej Topolcan; Lubos Holubec
The role of thymidine kinase in cancer diseases.
Expert opinion on medical diagnostics 2008;2(2):129-41.
2008: Katerina Linhartová; Josef Veselka; Gabriela Sterbáková; Jaroslav Racek; Ondrej Topolcan; Roman Cerbák
Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis.
Circulation journal : official journal of the Japanese Circulation Society 2008;72(2):245-50.
2008: M Levy; Vladimir Visokai; Ludmila Lipska; Ondrej Topolcan
Tumor markers in staging and prognosis of colorectal carcinoma.
Neoplasma 2008;55(2):138-42.
2007: Zdenek Hess; Jirí Podlipný; Hana Rosolová; Ondrej Topolcan; Barbora Petrlová
[Cortisol levels are more closely associated with depressiveness and other psychopathologies than catecholamine levels].
Vnitr̆ní lékar̆ství 2007;53(10):1040-6.
2007: Vaclav Liska; Vladislav Treska; Lubos Holubec; Stanislav Kormunda; Tomas Skalicky; Alan Sutnar; Ondrej Topolcan
Recurrence of colorectal liver metastases after surgical treatment: multifactorial study.
Hepato-gastroenterology 2007;54(78):1741-4.
2007: J Safranek; Lubos Holubec; Ondrej Topolcan; Martin Pesta; Jirí Klecka; J Vodicka; Jindrich Finek; Stanislav Kormunda; M Pesek
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Anticancer research 2007;27(4C):2953-6.
2007: Vaclav Liska; Lubos Holubec; Vladislav Treska; Tomas Skalicky; Alan Sutnar; Stanislav Kormunda; Martin Pesta; Jindrich Finek; M Rousarova; Ondrej Topolcan
Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases.
Anticancer research 2007;27(4C):2861-4.
2007: Jana Slavíková; Jitka Kuncová; Ondrej Topolcan
Plasma catecholamines and ischemic heart disease.
Clinical cardiology 2007;30(7):326-30.
2007: Tomas Votava; Ondrej Topolcan; Lubos Holubec; Zdenka Cerna; Lumir Sasek; Jindrich Finek; Stanislav Kormunda
Changes of serum thymidine kinase in children with acute leukemia.
Anticancer research 2007;27(4A):1925-8.
2007: Ondrej Topolcan; Lubos Holubec; V Polivkova; Sarka Svobodova; M Pesek; Vladislav Treska; J Safranek; T Hajek; L Bartunek; M Rousarova; Jindrich Finek
Tumor markers in pleural effusions.
Anticancer research 2007;27(4A):1921-4.
2007: Sarka Svobodova; Ondrej Topolcan; Lubos Holubec; Vladislav Treska; Alan Sutnar; K Rupert; Stanislav Kormunda; M Rousarova; Jindrich Finek
Prognostic importance of thymidine kinase in colorectal and breast cancer.
Anticancer research 2007;27(4A):1907-9.
2007: Jindrich Finek; Lubos Holubec; Ondrej Topolcan; L Elgrova; A Skalova; Ladislav Pecen
The importance of prognostic factors in premenopausal women with breast cancer.
Anticancer research 2007;27(4A):1893-6.
2007: Vaclav Liska; Lubos Holubec; Vladislav Treska; Tomas Skalicky; Alan Sutnar; Ondrej Topolcan; Stanislav Kormunda; Jindrich Finek
Tumor markers as useful predictors of survival rate after exploratory laparotomy for liver malignancies.
Anticancer research 2007;27(4A):1887-91.
2007: Lubos Holubec; Ondrej Topolcan; Jindrich Finek; J Salvet; T Svoboda; Sarka Svobodova; P Mrazkova; M Ludvikova
Dynamic monitoring of cardio-specific markers and markers of thyroid gland function in cancer patients--a pilot study.
Anticancer research 2007;27(4A):1883-6.
2007: D Jancarikova; M Pesek; Lucie Benesova; Ondrej Topolcan; Lubos Holubec; Marek Minarik
Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M.
Anticancer research 2007;27(4A):1879-82.
2007: Martin Pesta; Ondrej Topolcan; Lubos Holubec; K Rupert; Monika Cerna; L Sen Holubec; Vladislav Treska; Jindrich Finek; Radim Cerny
Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
Anticancer research 2007;27(4A):1863-7.
2007: Michael J Duffy; Arie Van Dalen; C Haglund; L Hansson; E Holinski-Feder; R Klapdor; Rolf Lamerz; P Peltomaki; C Sturgeon; Ondrej Topolcan
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.
European journal of cancer (Oxford, England : 1990) 2007;43(9):1348-60.
2007: Alan Sutnar; Martin Pesta; Vaclav Liska; Vladislav Treska; Tomas Skalicky; Stanislav Kormunda; Ondrej Topolcan; Radim Cerny; Lubos Holubec
Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(5):247-52.
2007: Vladislav Eybl; Dana Kotyzová; Jindrich Sýkora; Ondrej Topolcan; Richard Pikner; Martin Mihaljevic; Július Brtko; Eystein Glattre
Effects of selenium and tellurium on the activity of selenoenzymes glutathione peroxidase and type I iodothyronine deiodinase, trace element thyroid level, and thyroid hormone status in rats.
Biological trace element research 2007;117(1-3):105-14.
2006: Vaclav Liska; Vladislav Treska; Lubos Holubec; T Skalický; A Sunar; Ondrej Topolcan; Jindrich Fínek
[Prognostic factors of early recurrence of colorectal liver metastases and their usage in clinical praxis].
Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti 2006;85(4):163-8.
2006: Vaclav Liska; Vladislav Treska; Lubos Holubec; T Skalický; Alan Sutnar; Ondrej Topolcan; Jindrich Fínek
[A partial relaps of a colorectal carcinoma metastatic process following liver surgery--a multifactorical study].
Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti 2006;85(2):86-9.
2006: Monika Cerna; Lubos Holubec; Martin Pesta; Stanislav Kormunda; Ondrej Topolcan; Radim Cerny
Quantitative estimation of CEA and CK20 expression in tumour tissue of colorectal cancer and its liver metastases with reverse transcription and real-time PCR.
Anticancer research 2006;26(1B):803-8.
2005: Sylvie Opatrná; Jan Klaboch; Karel Opatrný; Lubos Holubec; Martina Tomsů; Frantisek Sefrna; Ondrej Topolcan
Procalcitonin levels in peritoneal dialysis patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2005;25(5):470-2.
2005: Martin Pesta; L Holubec; Ondrej Topolcan; Monika Cerna; K Rupert; Lubos Holubec; Vladislav Treska; Stanislav Kormunda; L Elgrova; Jindrich Finek; Radim Cerny
Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Anticancer research 2005;25(5):3387-91.
2005: Hana Rosolova; Jakub Cech; Jaroslav Simon; Jindrich Spinar; Ruzena Jandova; Jiri Widimský sen; Lubos Holubec; Ondrej Topolcan
Short to long term mortality of patients hospitalised with heart failure in the Czech Republic--a report from the EuroHeart Failure Survey.
European journal of heart failure 2005;7(5):780-3.
2005: Jindrich Finek; Lubos Holubec; Ondrej Topolcan; J Salvet; Richard Pikner; Stefan Holdenrieder; Petra Stieber; Rolf Lamerz; L Holubec Sen; Sarka Svobodova; Vladimir Visokai; E Helmichova
Clinical relevance of tumor markers for the control of chemotherapy.
Anticancer research 2005;25(3A):1655-8.
2005: Marie Ludvíková; Lubos Holubec; Aleš Ryška; Ondrej Topolcan
Proliferative markers in diagnosis of thyroid tumors: a comparative study of MIB-1 and topoisomerase II-a immunostaining.
Anticancer research 2005;25(3A):1835-40.
2005: Ondrej Topolcan; Lubos Holubec; Jindrich Finek; Petra Stieber; Stefan Holdenrieder; Rolf Lamerz; L Holubec Sen; Sarka Svobodova; Vladimir Visokai; Ludmila Lipska
Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapy.
Anticancer research 2005;25(3A):1831-3.
2005: Stefan Holdenrieder; Lubos Holubec; Ondrej Topolcan; Jindrich Finek; Petra Stieber
Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapy.
Anticancer research 2005;25(3A):1795-801.
2005: Lubos Holubec; Ondrej Topolcan; Jindrich Finek; Stefan Holdenrieder; Petra Stieber; Martin Pesta; Richard Pikner; L Holubec Sen; Alan Sutnar; Vaclav Liska; Sarka Svobodova; Vladimir Visokai; Stanislav Kormunda
Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma.
Anticancer research 2005;25(3A):1597-601.
2005: Richard Pikner; M Ludvíkova; Aleš Ryška; I Kholova; Lubos Holubec; Ondrej Topolcan; Ladislav Pecen; Jindrich Fínek
TPS, thymidine kinase, VEGF and endostatin in cytosol of thyroid tissue samples.
Anticancer research 2005;25(3A):1517-21.
2005: Otto Mayer; J Simon; J Hrbková; Richard Pikner; Ondrej Topolcan
[Epidemiological study of hypothyroidism as cardiovascular risk in population].
Casopís lékar̆ů c̆eských 2005;144(7):459-64; discussion 464-5.
2005: Lubos Holubec; Jindrich Finek; Ondrej Topolcan; Sárka Svobodová
[Serum tumor markers at exocrine adenocarcinoma of pancreas].
Casopís lékar̆ů c̆eských 2005;144(2):86-8; discussion 89.
2004: Zdenek Rusavý; Vladimir Sramek; Renata Suchat; Silvie Lacigova; Ondrej Topolcan
Effects of carrier solution on insulin bioavailability.
JPEN. Journal of parenteral and enteral nutrition 2004;28(6):439-41.
2004: T Hájek; L Bartůnĕk; Ondrej Topolcan; V Polívková; Zdenek Hess; Lubos Holubec
[The role of procalcitonin in the patient assessment after surgical procedures].
Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti 2004;83(7):337-41.
2004: Lubos Holubec; Jindrich Fínek; Ondrej Topolcan; J Jun Bouda; Zdenek Rokyta
[Clinical relevance of tumor markers in epithelial ovarian cancer].
Ceská gynekologie / Ceská lékarská spolecnost J. Ev. Purkyne 2004;69(3):225-8.
2004: Stepan Svacina; M Matoulek; Sárka Svobodová; Vladimir Visokai; Ludmila Lipská; Ondrej Topolcan; Jana Zvárová; M Plavcová
[Gastrointestinal tract cancer and diabetes mellitus].
Vnitr̆ní lékar̆ství 2004;50(5):386-91.
2004: Vladislav Treska; T Skalický; Jindrich Fínek; Stanislav Kormunda; Ondrej Topolcan; Alan Sutnar; P Neprasová; B Sůvová
[Is liver resection or radiofrequency ablation indicated in breast carcinoma metastases?].
Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti 2004;83(4):173-7.
2004: Zdenek Hess; Hana Rosolová; Jirí Podlipný; Lubos Holubec; Ondrej Topolcan; Barbora Petrlová
[Metabolic syndrome and latent depression in the population sample].
Casopís lékar̆ů c̆eských 2004;143(12):840-4; discussion 844-6.
2004: Jindrich Fínek; Lubos Holubec; Ondrej Topolcan; Richard Pikner; B Sůvová; Vladislav Treska
[Clinical importance of determination of tumor markers during follow-up in breast carcinoma].
Casopís lékar̆ů c̆eských 2004;143(3):174-7.
2003: Jan Mares; Sylvie Opatrná; Jirí Ferda; Karel Opatrný; Martina Tomsu; Frantisek Sefrna; Boris Kreuzberg; Ondrej Topolcan
Computed tomography-based assessment of bone mineral density in patients treated with peritoneal dialysis.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2003;23(6):601-3.
2003: Michael J Duffy; Arie Van Dalen; C Haglund; L Hansson; R Klapdor; Rolf Lamerz; O Nilsson; C Sturgeon; Ondrej Topolcan
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.
European journal of cancer (Oxford, England : 1990) 2003;39(6):718-27.
2003: Ivana Kholová; M Ludvíkova; Aleš Ryška; Ondrej Topolcan; Richard Pikner; Ladislav Pecen; Jan Cáp; Lubos Holubec
Diagnostic role of markers dipeptidyl peptidase IV and thyroid peroxidase in thyroid tumors.
Anticancer research 2003;23(2A):871-5.
2003: Lubos Holubec; Ondrej Topolcan; Richard Pikner; Ladislav Pecen; L Holubec Sen; Jindrich Finek; M Ludvikova; Monika Cerna
Criteria for the selection of referential groups in tumor marker statistical evaluation on the basis of a retrospective study.
Anticancer research 2003;23(2A):865-70.
2003: Ivana Kholová; Marie Ludvíková; Aleš Ryška; Z Hanzelková; J Cap; Ladislav Pecen; Ondrej Topolcan
Immunohistochemical detection of dipeptidyl peptidase IV (CD 26) in thyroid neoplasia using biotinylated tyramine amplification.
Neoplasma 2003;50(3):159-64.
2002: D Hauerová; Richard Pikner; Ondrej Topolcan; D Mrázová; Lubos Holubec; Ladislav Pecen
[Thyroid disease in pregnant women and its development after childbirth].
Vnitr̆ní lékar̆ství 2002;48(11):1060-4.
2002: Lubos Holubec; Ondrej Topolcan; Richard Pikner
[Biological activity in colorectal carcinoma].
Casopís lékar̆ů c̆eských 2002;141(16):508-12.
2002: Mirka Nekulova; Ladislav Pecen; Renata Kalabova; Marta Simickova; Ondrej Topolcan; Richard Pikner; Vladimir Vondracek; Dalibor Valik
Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125.
Clinical chemistry 2002;48(8):1364-7.
2002: D Hauerová; Richard Pikner; Ondrej Topolcan; D Mrázová; Lubos Holubec; Ladislav Pecen
[Prevalence of thyroid gland disorders in pregnant women in the West Bohemia Region during their 2nd trimester of pregnancy in the year 2000--pilot study].
Vnitr̆ní lékar̆ství 2002;48(7):629-31.
2002: Sylvie Opatrná; Jaroslav Racek; Pavel Stehlík; Václav Senft; Frantisek Sefrna; Ondrej Topolcan; Karel Opatrný
[Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
Casopís lékar̆ů c̆eských 2002;141(9):281-5.
2002: Vladislav Treska; Jitka Kocova; Ludmila Boudova; Petra Neprasova; Ondrej Topolcan; Ladislav Pecen; Zbynek Tonar
Inflammation in the wall of abdominal aortic aneurysm and its role in the symptomatology of aneurysm.
Cytokines, cellular & molecular therapy 2002;7(3):91-7.
2000: Sylvie Opatrná; Ondrej Topolcan; Karel Opatrný
[The role of cytokines in peritoneal dialysis].
Vnitr̆ní lékar̆ství 2000;46(11):794-800.
2000: Lubos Holubec; Ondrej Topolcan; Richard Pikner; Ladislav Pecen; J Vaclavickova; M Wirthova; J Molacek; Petra Stieber; Stefan Holdenrieder; L H Sen; Jindrich Finek
The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
Anticancer research 2000;20(6D):5237-44.
1999: Vladislav Treska; Ondrej Topolcan; J Kocová; Ladislav Pecen; Zbynek Tonar
[Type I and III procollagen in patients with abdominal aorta aneurysms].
Casopís lékar̆ů c̆eských 1999;138(5):142-6.
1998: Vladislav Treska; Ondrej Topolcan; P W Wenham; Ladislav Pecen; J Kocová
[Cytokine metabolism in aneurysms of the abdominal aorta].
Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti 1998;77(5):225-9.